Medite Cancer Diagnostics, Inc. (MDIT)
Seasonality Analysis
Medite Cancer Diagnostics, Inc. Annual Seasonality Statistics
Medite Cancer Diagnostics, Inc. Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January | 35.67% | Moderate | |
| February | 9.65% | Weak | |
| March | -0.41% | Very Weak | |
| April | 2.04% | Weak | |
| May | -0.81% | Very Weak | |
| June | 12.14% | Weak | |
| July WORST | -16.04% | Very Weak | |
| August | 191.68% | Weak | |
| September | 2.83% | Weak | |
| October | 7.54% | Weak | |
| November BEST | 365.60% | Weak | |
| December | -0.32% | Very Weak |
Medite Cancer Diagnostics, Inc. Interactive Seasonality Chart
Medite Cancer Diagnostics, Inc. Pattern Scanner
Medite Cancer Diagnostics, Inc. Seasonal Historical Performance
About Medite Cancer Diagnostics, Inc. (MDIT) Seasonality
Medite Cancer Diagnostics, Inc. (MDIT) has been analyzed using 27 years of historical data to identify seasonal patterns. Classified under Stocks, Medite Cancer Diagnostics, Inc. shows distinct seasonal tendencies based on historical data.
The strongest month for Medite Cancer Diagnostics, Inc. is historically November, with an average return of 365.60% and a win rate of 23%. Conversely, July tends to be the weakest month, averaging -16.04% return.
Looking at the full calendar year, Medite Cancer Diagnostics, Inc. has an average annual return of 609.57% with an overall monthly win rate of 34.1%. Out of 12 months, 8 typically show positive average returns.
The seasonal pattern for Medite Cancer Diagnostics, Inc. has a consistency score of 44.2 (Poor), based on 27 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
Medite Cancer Diagnostics, Inc. Seasonality FAQ
What is the best month to buy Medite Cancer Diagnostics, Inc. (MDIT)?
Historically, November has been the best month for Medite Cancer Diagnostics, Inc., with an average return of 365.60% and a win rate of 23%. However, past performance does not guarantee future results.
What is the worst month for Medite Cancer Diagnostics, Inc. (MDIT)?
Based on historical data, July has been the weakest month for Medite Cancer Diagnostics, Inc., with an average return of -16.04%. This is a historical observation and does not guarantee future results.
How reliable is MDIT seasonality data?
The seasonality analysis for Medite Cancer Diagnostics, Inc. is based on 27 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use Medite Cancer Diagnostics, Inc. seasonality in my trading?
Use Medite Cancer Diagnostics, Inc. (MDIT) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.